Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

CTMX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $122,204.29

CytomX Therapeutics Insider Trading History Chart

CytomX Therapeutics Share Price & Price History

^$0.89

▲ +0.02 (2.30%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

CytomX Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/20/2024	Christopher Ogden	CFO	Sell	1,984	$1.23	$2,440.32	108,077
8/20/2024	Jeffrey B Landau	Insider	Sell	4,181	$1.23	$5,142.63	119,056
8/20/2024	Sean A. McCarthy	CEO	Sell	13,898	$1.23	$17,094.54	657,851
3/19/2024	Christopher Ogden	SVP	Sell	2,971	$2.09	$6,209.39	85,686
3/19/2024	Jeffrey B Landau	Insider	Sell	6,562	$2.09	$13,714.58	110,060
3/19/2024	Lloyd A Rowland	General Counsel	Sell	5,268	$2.09	$11,010.12	117,728
3/19/2024	Sean A. McCarthy	CEO	Sell	20,223	$2.09	$42,266.07	524,481
12/20/2023	Marcia Belvin	SVP	Sell	4,077	$1.38	$5,626.26	155,124
12/20/2023	Sean A. McCarthy	CEO	Sell	13,551	$1.38	$18,700.38	454,704
9/22/2023	Lloyd A Rowland	General Counsel	Sell	5,486	$1.30	$7,131.80	80,609
9/22/2023	Marcia Belvin	SVP	Sell	4,119	$1.30	$5,354.70	147,951
9/22/2023	Sean A. McCarthy	CEO	Sell	14,601	$1.30	$18,981.30	430,755
3/29/2023	Elaine V Jones	Director	Buy	5,000	$1.55	$7,750.00	5,142
3/16/2023	Amy C Peterson	EVP	Sell	4,257	$1.98	$8,428.86	58,433
3/16/2023	Carlos Campoy	CFO	Sell	1,748	$1.98	$3,461.04	38,224
3/16/2023	Christopher Ogden	SVP	Sell	516	$1.98	$1,021.68	37,772
3/16/2023	Lloyd A Rowland	General Counsel	Sell	2,037	$1.98	$4,033.26	71,095
3/16/2023	Sean A. McCarthy	CEO	Sell	7,121	$1.88	$13,387.48	388,821
7/20/2022	Amy C Peterson	EVP	Sell	7,463	$1.42	$10,597.46	62,690
7/20/2022	Carlos Campoy	CFO	Sell	3,949	$1.42	$5,607.58	39,972
7/20/2022	Jeffrey B Landau	Insider	Sell	4,206	$1.42	$5,972.52	30,725
7/20/2022	Lloyd A Rowland	General Counsel	Sell	5,602	$1.42	$7,954.84	43,689
7/20/2022	Sean A. McCarthy	CEO	Sell	14,911	$1.42	$21,173.62	290,942

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for CytomX Therapeutics (NASDAQ:CTMX)

67.77% of CytomX Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CytomX Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Virtu Financial LLC	88,518	$0.10M	0.0%	N/A	0.113%
11/16/2024	Geode Capital Management LLC	803,531	$0.95M	0.0%	+4.4%	1.027%
11/15/2024	XTX Topco Ltd	43,664	$52K	0.0%	-27.9%	0.056%
11/15/2024	Jane Street Group LLC	27,231	$32K	0.0%	-65.8%	0.035%
11/15/2024	Jacobs Levy Equity Management Inc.	1,524,076	$1.80M	0.0%	+1.1%	1.947%
11/15/2024	Janus Henderson Group PLC	4,809,518	$5.70M	0.0%	-23.7%	6.146%
11/13/2024	FMR LLC	284,307	$0.34M	0.0%	+17.3%	0.363%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	280,593	$0.33M	0.0%	+10.4%	0.359%
11/6/2024	Cornercap Investment Counsel Inc.	41,458	$49K	0.0%	-48.6%	0.053%
10/28/2024	US Bancorp DE	33,792	$40K	0.0%	N/A	0.043%
10/23/2024	Assenagon Asset Management S.A.	1,644,168	$1.94M	0.0%	+32.8%	2.110%
10/9/2024	Congress Park Capital LLC	1,216,008	$1.44M	0.5%	+5.4%	1.561%
9/16/2024	Cubist Systematic Strategies LLC	82,054	$100K	0.0%	+96.6%	0.105%
8/16/2024	Forefront Analytics LLC	64,065	$78K	0.0%	+206.7%	0.082%
8/14/2024	Squarepoint Ops LLC	198,840	$0.24M	0.0%	-22.7%	0.255%
8/14/2024	Cubist Systematic Strategies LLC	82,054	$100K	0.0%	+96.6%	0.105%
8/13/2024	Sei Investments Co.	382,723	$0.47M	0.0%	N/A	0.491%
8/12/2024	XTX Topco Ltd	60,586	$74K	0.0%	+382.6%	0.078%
8/9/2024	Renaissance Technologies LLC	1,183,022	$1.44M	0.0%	-4.0%	1.518%
8/6/2024	Acadian Asset Management LLC	2,728,569	$3.32M	0.0%	+1.4%	3.502%
8/6/2024	Candriam S.C.A.	210,027	$0.26M	0.0%	N/A	0.270%
7/18/2024	Assenagon Asset Management S.A.	1,238,499	$1.51M	0.0%	+206.0%	1.589%
7/12/2024	Congress Park Capital LLC	1,153,220	$1.41M	0.6%	+393.3%	1.480%
5/17/2024	Tidal Investments LLC	288,101	$0.63M	0.0%	-5.9%	0.370%
5/16/2024	Jacobs Levy Equity Management Inc.	529,935	$1.16M	0.0%	-33.0%	0.680%
5/10/2024	Acadian Asset Management LLC	2,690,830	$5.86M	0.0%	+1.7%	3.949%
5/10/2024	Vanguard Group Inc.	4,857,374	$10.59M	0.0%	-0.9%	7.129%
5/7/2024	Susquehanna Fundamental Investments LLC	56,745	$0.12M	0.0%	N/A	0.083%
5/7/2024	SG Americas Securities LLC	26,114	$57K	0.0%	N/A	0.038%
4/16/2024	Congress Park Capital LLC	233,800	$0.51M	0.2%	-2.3%	0.345%
2/15/2024	Forefront Analytics LLC	30,846	$48K	0.0%	-37.6%	0.046%
2/7/2024	Formidable Asset Management LLC	306,107	$0.47M	0.1%	-3.8%	0.457%
1/19/2024	Congress Park Capital LLC	239,300	$0.37M	0.2%	+112.8%	0.357%
1/19/2024	AlphaMark Advisors LLC	23,183	$36K	0.0%	+119.8%	0.035%
1/17/2024	Assenagon Asset Management S.A.	404,674	$0.63M	0.0%	-5.0%	0.604%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	145,934	$0.19M	0.0%	-6.5%	0.218%
11/6/2023	Assenagon Asset Management S.A.	425,921	$0.55M	0.0%	-36.2%	0.638%
10/24/2023	Bank of New York Mellon Corp	266,836	$0.34M	0.0%	+737.4%	0.400%
8/8/2023	Bronte Capital Management Pty Ltd.	925,245	$1.59M	0.2%	+0.8%	1.395%
7/14/2023	Congress Park Capital LLC	106,150	$0.18M	0.1%	+5.9%	0.160%
5/12/2023	Tejara Capital Ltd	157,928	$0.24M	0.1%	-33.1%	0.238%
5/11/2023	Cornercap Investment Counsel Inc.	82,415	$0.12M	0.0%	-44.4%	0.124%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	134,309	$0.20M	0.0%	-11.1%	0.202%
5/1/2023	Virtu Financial LLC	24,136	$36K	0.0%	N/A	0.036%
4/20/2023	Congress Park Capital LLC	100,200	$0.15M	0.1%	N/A	0.151%
4/18/2023	Assenagon Asset Management S.A.	668,032	$1.01M	0.0%	-27.0%	1.009%
2/15/2023	Tang Capital Management LLC	3,510,445	$5.62M	0.8%	+0.3%	5.312%
2/13/2023	Platinum Investment Management Ltd.	635,798	$1.02M	0.0%	-48.3%	0.962%
2/13/2023	Forefront Analytics LLC	24,787	$40K	0.0%	-48.2%	0.038%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	151,020	$0.24M	0.0%	-28.3%	0.229%
2/9/2023	CM Management LLC	75,000	$0.12M	0.1%	N/A	0.113%
2/7/2023	Commonwealth Equity Services LLC	53,243	$85K	0.0%	N/A	0.081%
2/7/2023	Formidable Asset Management LLC	318,233	$0.51M	0.1%	+2.2%	0.482%
2/1/2023	Bank of Montreal Can	69,600	$0.12M	0.0%	N/A	0.105%
1/12/2023	Assenagon Asset Management S.A.	914,900	$1.46M	0.0%	-14.1%	1.384%
1/10/2023	FNY Investment Advisers LLC	65,000	$0.10M	0.1%	N/A	0.098%
11/23/2022	Toroso Investments LLC	311,315	$0.45M	0.0%	+49.8%	0.471%
11/15/2022	Tang Capital Management LLC	3,500,000	$5.08M	0.6%	+231.9%	5.296%
11/15/2022	Formidable Asset Management LLC	311,315	$0.45M	0.1%	+49.8%	0.471%
11/15/2022	BVF Inc. IL	6,595,801	$9.56M	0.4%	+13.6%	9.982%
11/14/2022	Ergoteles LLC	279,056	$0.41M	0.0%	-12.2%	0.422%
11/14/2022	Forefront Analytics LLC	47,869	$71K	0.0%	+33.3%	0.072%
11/9/2022	Magnus Financial Group LLC	20,000	$29K	0.0%	N/A	0.030%
11/8/2022	AlphaCentric Advisors LLC	257,500	$0.37M	0.4%	N/A	0.390%
11/4/2022	Russell Investments Group Ltd.	61,320	$88K	0.0%	-74.0%	0.093%
10/27/2022	Assenagon Asset Management S.A.	1,065,392	$1.55M	0.0%	N/A	1.615%
8/16/2022	Formidable Asset Management LLC	207,772	$0.38M	0.1%	N/A	0.315%
8/15/2022	Clearline Capital LP	196,583	$0.36M	0.0%	+3.1%	0.298%
8/15/2022	Point72 Asset Management L.P.	2,750,000	$5.03M	0.0%	-37.1%	4.170%
8/15/2022	Laurion Capital Management LP	1,270,900	$2.33M	0.0%	N/A	1.927%
8/15/2022	Knightsbridge Asset Management LLC	96,926	$0.18M	0.0%	N/A	0.147%
8/11/2022	Platinum Investment Management Ltd.	1,229,545	$2.25M	0.1%	+25.5%	1.864%
8/10/2022	Gladius Capital Management LP	13,172	$25K	0.0%	N/A	0.020%
8/10/2022	Forefront Analytics LLC	35,919	$67K	0.0%	+145.3%	0.054%
8/9/2022	Pictet Asset Management SA	660,495	$1.21M	0.0%	+87.0%	1.002%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	207,071	$0.38M	0.0%	+3.4%	0.317%
7/29/2022	Russell Investments Group Ltd.	235,470	$0.43M	0.0%	+175.8%	0.360%
5/17/2022	RTW Investments LP	5,779,700	$15.43M	0.3%	-4.1%	8.837%
5/16/2022	Clearline Capital LP	190,600	$0.51M	0.1%	+31.4%	0.291%
5/12/2022	CI Investments Inc.	60,992	$0.16M	0.0%	N/A	0.093%
5/12/2022	Acadian Asset Management LLC	885,107	$2.36M	0.0%	+115.2%	1.353%
5/12/2022	Healthcare of Ontario Pension Plan Trust Fund	1,290,600	$3.45M	0.0%	N/A	1.973%
5/5/2022	Russell Investments Group Ltd.	85,379	$0.23M	0.0%	-34.9%	0.131%
2/15/2022	Rubric Capital Management LP	2,406,449	$10.42M	0.5%	N/A	3.688%
2/15/2022	Sender Co & Partners Inc.	40,720	$0.18M	0.1%	N/A	0.062%
2/14/2022	PDT Partners LLC	135,123	$0.59M	0.0%	+27.7%	0.207%
2/14/2022	Clearline Capital LP	145,000	$0.63M	0.1%	N/A	0.222%
2/14/2022	Altium Capital Management LP	663,800	$2.87M	0.8%	-46.2%	1.017%
2/10/2022	Private Advisor Group LLC	84,179	$0.37M	0.0%	-32.3%	0.129%
2/10/2022	Candriam Luxembourg S.C.A.	1,760,922	$7.62M	0.0%	-46.7%	2.699%
2/10/2022	Pictet Asset Management SA	288,326	$1.25M	0.0%	N/A	0.442%
2/10/2022	Rafferty Asset Management LLC	152,369	$0.66M	0.0%	-3.7%	0.234%
2/10/2022	Acadian Asset Management LLC	411,222	$1.78M	0.0%	-41.3%	0.630%
2/10/2022	Massachusetts Financial Services Co. MA	357,134	$1.55M	0.0%	-8.0%	0.547%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	201,758	$0.87M	0.0%	+267.2%	0.309%
2/9/2022	Principal Financial Group Inc.	10,099	$44K	0.0%	-60.6%	0.015%
2/9/2022	Alps Advisors Inc.	75,513	$0.33M	0.0%	-5.4%	0.116%
2/9/2022	Dimensional Fund Advisors LP	522,027	$2.26M	0.0%	+61.6%	0.800%
2/8/2022	Raymond James Financial Services Advisors Inc.	10,227	$44K	0.0%	N/A	0.016%
2/8/2022	Northern Trust Corp	615,321	$2.66M	0.0%	-6.0%	0.943%

Data available starting January 2016

CytomX Therapeutics, Inc., an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines; and PROBODY platform in preclinical research in areas outside of oncology. It also develops CX-904, a T-cell-engaging bispecific antibody targeting the epidermal growth factor receptor (EGFR) on tumor cells and the CD3 receptor on T cells; CX-2051, a conditionally activated ADC for optimizing the therapeutic index for EpCAM-expressing epithelial cancers, including colorectal cancer; and CX-801, an interferon alpha-2b PROBODY cytokine. In addition, the company's development pipeline comprises CX-2029, a conditional activated ADC targeting CD71; and BMS-986288, a PROBODY version of non-fucosylated ipilimumab. It has strategic collaborations with Amgen, Astellas, Bristol Myers Squibb, Regeneron, and Moderna. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.

Today's Range

Now: $0.89

$0.86

$0.90

50 Day Range

MA: $1.08

$0.86

$1.21

52 Week Range

Now: $0.89

$0.83

$5.85

Volume

494,958 shs

Average Volume

1,156,407 shs

Market Capitalization

$69.65 million

P/E Ratio

5.24

Dividend Yield

N/A

Beta

1.06

Who are the company insiders with the largest holdings of CytomX Therapeutics?: CytomX Therapeutics' top insider investors include:
Sean A Mccarthy (CEO)
Marcia Belvin (SVP)
Jeffrey B Landau (Insider)
Lloyd A Rowland (General Counsel)
Christopher Ogden (CFO)
Christopher Ogden (SVP)
Amy C Peterson (EVP)
Carlos Campoy (CFO)
Elaine V Jones (Director)
Learn More about top insider investors at CytomX Therapeutics.
Who are the major institutional investors of CytomX Therapeutics?: CytomX Therapeutics' top institutional investors include:
Janus Henderson Group PLC — 6.15%
Assenagon Asset Management S.A. — 2.11%
Jacobs Levy Equity Management Inc. — 1.95%
Congress Park Capital LLC — 1.56%
Geode Capital Management LLC — 1.03%
FMR LLC — 0.36%
Learn More about top institutional investors of CytomX Therapeutics stock.
Which institutional investors are selling CytomX Therapeutics stock?: During the previous quarter, CTMX stock was sold by these institutional investors:
Janus Henderson Group PLC
Jane Street Group LLC
Cornercap Investment Counsel Inc.
XTX Topco Ltd
In the last year, company insiders that have sold CytomX Therapeutics company stock include:
Sean A Mccarthy (CEO)
Marcia Belvin (SVP)
Jeffrey B Landau (Insider)
Lloyd A Rowland (General Counsel)
Christopher Ogden (CFO)
Christopher Ogden (SVP)
Learn More investors selling CytomX Therapeutics stock.
Which institutional investors are buying CytomX Therapeutics stock?: In the last quarter, CTMX stock was purchased by institutional investors including:
Assenagon Asset Management S.A.
Virtu Financial LLC
Congress Park Capital LLC
FMR LLC
Geode Capital Management LLC
US Bancorp DE
Connor Clark & Lunn Investment Management Ltd.
Jacobs Levy Equity Management Inc.